Caris Life Sciences, Inc.
CAI
$37.94
-$0.54-1.40%
NASDAQ
| 06/30/2025 | 03/31/2025 | 06/30/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 721.18M | 33.43M | -- | ||
| Total Receivables | 50.89M | 80.17M | -- | ||
| Inventory | 40.61M | 36.55M | -- | ||
| Prepaid Expenses | 16.58M | 11.92M | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 4.06M | 9.16M | -- | ||
| Total Current Assets | 833.32M | 171.23M | -- | ||
|
|
|||||
| Total Current Assets | 833.32M | 171.23M | -- | ||
| Net Property, Plant & Equipment | 61.32M | 61.65M | -- | ||
| Long-term Investments | 19.34M | 19.34M | -- | ||
| Goodwill | 19.34M | 19.34M | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 41.08M | 39.36M | -- | ||
| Total Assets | 955.06M | 291.58M | -- | ||
|
|
|||||
| Total Accounts Payable | 28.73M | 24.23M | -- | ||
| Total Accrued Expenses | 48.73M | 64.55M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 7.39M | 66.12M | -- | ||
| Total Finance Division Other Current Liabilities | 5.34M | 7.66M | -- | ||
| Total Other Current Liabilities | 5.34M | 7.66M | -- | ||
| Total Current Liabilities | 90.18M | 162.55M | -- | ||
|
|
|||||
| Total Current Liabilities | 90.18M | 162.55M | -- | ||
| Long-Term Debt | 373.61M | 316.64M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 37.98M | 37.07M | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 380.00K | 129.07M | -- | ||
| Total Liabilities | 502.15M | 645.34M | -- | ||
|
|
|||||
| Common Stock & APIC | 3.12B | 145.00K | -- | ||
| Retained Earnings | -2.66B | -2.58B | -- | ||
| Treasury Stock & Other | -16.25M | -16.67M | -- | ||
| Total Common Equity | 452.90M | -2.60B | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 2.25B | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 2.25B | -- | ||
|
|
|||||
| Total Common Equity | 452.90M | -2.60B | -- | ||
| Total Preferred Equity | -- | 2.25B | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 452.90M | -353.75M | -- | ||
|
|
|||||